Results 151 to 160 of about 4,015 (203)

Antimalarial compounds exhibit variant- and cell-type-specific activity against SARS-CoV-2 isolated in Panama. [PDF]

Front Pharmacol
Quijada M, Castillo-Bultron M, Díaz Y, Pitti Y, Franco D, De La Guardia C, Campos D, Cornejo E, Núñez M, Mendoza L, López-Vergès S, Magallon-Tejada AH, Obaldia N.   +12 more
europepmc   +1 more source

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of [PDF]

core   +1 more source

Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. [PDF]

Malar J
Edler P, Rajasekhar M, Price DJ, Adam I, Awab GR, Barber BE, Brasil LW, Chamma-Siqueira NN, Chu CS, Cui L, Daher A, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Ley B, Lidia K, Llanos-Cuentas A, Longley RJ, Manning L, Mekonnen DA, Monteiro WM, Moore BR, Nosten F, Pasaribu AP, Pereira DB, Poespoprodjo JR, Pukrittayakamee S, Rijal KR, Saravu K, Siqueira AM, Sutanto I, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Yeshiwondim AK, Zuluaga-Idarraga LM, Guerin PJ, Simpson JA, Price RN, Commons RJ, WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group.   +47 more
europepmc   +1 more source

Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant <i>Plasmodium falciparum</i>. [PDF]

J Med Chem
Handford MJ, Li Y, Riscoe T, Liebman KM, Zhang X, Kelly JX, Riscoe MK.   +6 more
europepmc   +1 more source

Atypical Presentation of Homozygous UROD Mutation: Porphyria Cutanea Tarda or Mild Hepatoerythropoietic Porphyria? [PDF]

Clin Genet
Dotto PG, de Azevedo Vasconccellos MR, da Silva Franco JF, Gomes CP, Pesquero JB.   +4 more
europepmc   +1 more source

Chemoproteomics-based profiling elucidates the antimalarial effects of amodiaquine through disruption of glycolysis process in Plasmodium falciparum. [PDF]

Cell Commun Signal
Wang J, Wang C, Zhuge R, Tang H, Xia F, Zhang Y, Zhang J, Liu C, Wu J, Chen X, Gao P, Wang J.   +11 more
europepmc   +1 more source

No G6PD A- (G202A) variant detected among <i>Plasmodium falciparum</i>-positive patients in Awka, Southeast Nigeria: a hospital-based study. [PDF]

Malariaworld J
Ikegbunam M, Uchechukwu N, Abone H, Grace AE, Ezeunala M, Joy N, Immaculata NC, Igwe JO, Okeke O, Nworji F, Ihekwereme P.   +10 more
europepmc   +1 more source

Efficacy and safety of pyrotinib-based regimens in patients with HER2-positive stage III/IV breast cancer: a real-world retrospective study in China. [PDF]

PeerJ
Zhi L, Huang L, Pang X, Wu Q, Lei Y.
europepmc   +1 more source

Radical Cure of Plasmodium Vivax Malaria: How can we Improve 8-Aminoquinoline Implementation? [PDF]

Ethiop J Health Sci
Yilma D.
europepmc   +1 more source

2-Azidobenzaldehyde-Based [4+2] Annulation for the Synthesis of Quinoline Derivatives. [PDF]

Molecules
Zhang X, Liu M, Qiu W, Zhang W.
europepmc   +1 more source